NCT01026779

Brief Summary

The goals of this study are to see what effects the introduction of RV5(RotaTeq) vaccine has had in the community both on the number of rotavirus-associated hospitalizations and on the strains of rotavirus circulating in the community. The investigators will use cases of rotavirus gastroenteritis identified on the wards at Hasbro Children's Hospital during the 2007-2009 rotavirus seasons for a case-control study to estimate rotavirus vaccine effectiveness in preventing rotavirus-associated hospitalizations. The investigators plan to assess rotavirus vaccine coverage in Rhode Island using the state vaccine registry and to examine whether and to what extent rotavirus vaccine was used outside the recommended age limits (off label) during the first 2 years of its implementation in Rhode Island. Finally using the state child health database, KIDSNET the investigators plan to investigate the reasons that children may not have received rotavirus vaccine in order to better target educational efforts for parents and health care providers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
803

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 2, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 4, 2009

Completed
9.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
Last Updated

November 14, 2019

Status Verified

November 1, 2019

Enrollment Period

10.3 years

First QC Date

December 2, 2009

Last Update Submit

November 12, 2019

Conditions

Keywords

rotavirusgastroenteritisvaccinecase-control studyserotype

Outcome Measures

Primary Outcomes (1)

  • Rotavirus vaccine effectiveness in preventing rotavirus-associated hospitalizations

    Rotavirus vaccine effectiveness in preventing rotavirus-associated hospitalizations under field conditions

    2007-2009

Secondary Outcomes (4)

  • Vaccine use outside the recommended age limits

    2007-2009

  • Risk factors for non-receipt of rotavirus vaccine

    2007-2009

  • Characterize the strains of rotavirus circulating in the community

    2002-2009

  • Assess rotavirus vaccine coverage

    2007-2009

Study Arms (2)

Cases of rotavirus gastroenteritis

Patients will be eligible as cases if they have been identified by the investigator's ongoing rotavirus surveillance studies as having been hospitalized with laboratory-confirmed rotavirus gastroenteritis between January 1, 2007 and June 31, 2009. To be eligible as a case, the child must meet the following criteria: 1) immunocompetent; 2) born after April 15, 2006 (to select a population that would have been in the age group eligible for at least 1 dose of RV5 (RotaTeq); and 3) \> 2 months of age on the day of admission.

Control Subjects

Three controls for each case will be identified using KIDSNET, the state child health registry. Controls will be matched to cases by age and county of residence at birth.

Eligibility Criteria

Age2 Months - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Residents of Rhode Island

You may qualify if:

  • rotavirus gastroenteritis requiring hospitalization
  • immunocompetent
  • born after April 15, 2006
  • greater than 2 months of age on the day of admission

You may not qualify if:

  • rotavirus vaccine contraindicated for that child based on ACIP/AAP recommendations
  • an immunization record cannot be obtained through the KIDSNET database

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hasbro Children's Hospital

Providence, Rhode Island, 02903, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Stools

MeSH Terms

Conditions

Gastroenteritis

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Penelope H Dennehy, MD

    Rhode Island Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 2, 2009

First Posted

December 4, 2009

Study Start

July 1, 2009

Primary Completion

November 1, 2019

Study Completion

November 1, 2019

Last Updated

November 14, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

There is no plan to share IPD since the study uses a deidentified dataset and deidentified stool specimens for serotype analysis

Locations